Related Experiment Video
Updated: Jan 14, 2026
06:04
Surgical Treatment for Benign Prostatic Hyperplasia: Holmium Laser Enucleation of the Prostate HoLEP.
Published on: March 6, 2018
17.5K
UroLift, Rezūm, and iTind for Benign Prostatic Hyperplasia
Amandip S Cheema1, Bronwyn G Long1, Keenan E Moore2
1Department of Urology, Loyola University Medical Center, Maywood, IL, USA.
The Urologic Clinics of North America
|October 17, 2025
Summary
As men age, benign prostatic hyperplasia (BPH) increasingly causes lower urinary tract symptoms (LUTS). New treatments are needed to bridge the gap between medication side effects and invasive surgery for BPH.
Area of Science:
- Urology
- Geriatric Medicine
- Medical Technology
Background:
- Lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) are increasingly common in aging populations.
- Current treatments include pharmacotherapy, with its side effects, and surgical options like transurethral resection of the prostate (TURP).
Purpose of the Study:
- To explore treatment options for LUTS secondary to BPH.
- To identify a need for intermediate treatment options between pharmacotherapy and TURP.
Main Methods:
- Literature review of current BPH treatments.
- Analysis of treatment efficacy and side effect profiles.
Main Results:
- Pharmacotherapy for BPH often causes undesirable side effects.
- Transurethral resection of the prostate (TURP) is the established endoscopic standard but is invasive.
Conclusions:
- There is a significant need for minimally invasive treatment options for LUTS due to BPH.
- Developing treatments that offer an alternative to pharmacotherapy's side effects and TURP's invasiveness is crucial.
Related Concept Videos
01:21Drugs for Treatment of Constipation-Predominant IBS
712
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
712
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
457
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
457
01:28Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
554
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
554
01:17Drugs for Treatment of Diarrhea-Predominant IBS
625
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
625
01:22Imaging Studies V: Intravenous Urography and Retrograde Pyelography
1.1K
IntroductionIntravenous Urography (IVU) and Retrograde Pyelography (RP) are important diagnostic imaging techniques used to evaluate the urinary system. These methods help identify structural abnormalities, obstructions, and functional issues in the kidneys, ureters, and bladder. Both procedures use iodine-based contrast media to enhance the visibility of urinary tract structures on X-ray images, though they differ in their methods and indications.1. Intravenous Urography (IVU)Intravenous...
1.1K
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
438
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
438